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Abstract
Purpose This pilot study investigated differences in lean tissue mass, muscle strength, muscle quality (strength per unit of 
muscle mass; MQ), and functional performance in healthy younger and older individuals. The most robust predictors of 
appendicular lean mass (ALM) were then determined in each group.
Methods Fifty younger (18–45 years) and 50 older (60–80 years) participants completed tests of upper and lower body 
strength alongside body composition by dual-energy X-ray absorptiometry from which upper- and lower-body MQ were 
estimated. Available cut-points for older people were used to determine low upper-body MQ in both groups. Low lower-body 
MQ was determined as at least two standard deviations below the mean of the younger group. Functional performance was 
assessed by gait speed. Sarcopenia was identified using two established definitions.
Results Upper and lower body strength, ALM, lower-body MQ and gait speed were significantly higher in the younger 
group (all p < 0.002). Sarcopenia was identified in 2–4% of the older group. Low upper-body MQ was evident in 32% and 
42% of the younger and older group, respectively. Low lower-body MQ was observed in 4% of younger participants, and 
50% of older participants. In both groups, the most robust predictors of ALM were upper and lower body strength (young 
R2 = 0.74, 0.82; older R2 = 0.68, 0.72).
Conclusions Low MQ despite low prevalence rates of sarcopenia in both groups suggests a need for age-specific MQ cut-
points. Muscle quality assessments might be useful complementary prognostic tools alongside existing sarcopenia definitions.
Keywords Muscle mass · Dynapenia · Functional capacity · Strength · Ageing
Abbreviations
%TFM  Percentage tissue fat mass
1RM  One-repetition maximum
ALM  Appendicular lean mass
BMI  Body mass index
DBP  Diastolic blood pressure
DXA  Dual-energy X-ray absorptiometry
HGS  Handgrip strength
IPAQ  International Physical Activity Questionnaire
IWGS  International Working Group on Sarcopenia
MANOVA  Multivariate analysis of variance
MET  Metabolic equivalent
MQ  Muscle quality
RHR  Resting heart rate
SBP  Systolic blood pressure
SD  Standard deviation
VIF  Variance inflation factor
Introduction
The progressive loss of skeletal muscle mass and strength 
with age is associated with a number of adverse health out-
comes, such as decreased quality of life, functional impair-
ment, disability, increased risk of falls, hospitalisation, and 
mortality (Batsis et al. 2015; Beaudart et al. 2017; Lauretani 
et al. 2003; Bischoff-Ferrari et al. 2015; Cesari et al. 2009; 
Gariballa and Alessa 2013; Guralnik et al. 2000; Landi 
et al. 2013). The early identification of individuals with low 
muscle mass and impaired physical function may promote 
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desirable patient outcomes over the long-term. The term sar-
copenia was first used to describe the age-associated decline 
in skeletal muscle mass (Rosenberg 1989). This definition 
has expanded to include measures of both skeletal muscle 
mass and function to determine the presence of sarcope-
nia (Cruz-Jentoft et al. 2010; Goodpaster et al. 2006). The 
absence of a consensus definition for sarcopenia represents 
a considerable challenge for assessing its prevalence and 
impact on public health (Beaudart et al. 2014; Mayhew et al. 
2018; Batsis et al. 2015). Importantly, the prevalence of sar-
copenia appears to be greater when assessing muscle mass 
only (24.2–40.4%) as opposed to measures of muscle mass, 
strength and/or physical function in tandem (9.9–18.6%) 
(Mayhew et al. 2018).
Muscle quality (MQ), typically defined as muscle 
strength or power per unit of muscle mass (Barbat-Artigas 
et al. 2012), is a key determinant of muscle function in later 
life (McGregor et al. 2014), and declines with age (New-
man et al. 2003). A number of factors may mediate this, 
such as a decrease in the number and cross-sectional area of 
type II fibres, fat infiltration, and neurological derangements 
(McGregor et al. 2014; Fragala et al. 2015). Therefore, the 
inclusion of MQ assessment to augment existing sarcope-
nia definitions might serve as a more effective means of 
identifying individuals at risk of impaired mobility in later 
life (Cruz-Jentoft et al. 2018). Paradoxically, cut-points for 
handgrip strength have been lowered by the European Work-
ing Group on Sarcopenia in Older People (EWGSOP) (Cruz-
Jentoft et al. 2018) in comparison with previous recommen-
dations (Cruz-Jentoft et al. 2010). This reduces emphasis 
on MQ, since strength is a component of MQ determination 
(Barbat-Artigas et al. 2012).
In addition to assessing upper body strength, the assess-
ment of lower body strength and function in older adults 
is important, since age-related declines are faster in lower 
body than upper body strength (Goodpaster et al. 2006; 
Janssen et al. 2000). Incorporation of upper and lower body 
strength is preferential to upper body strength alone (Yeung 
et al. 2018). In addition, low knee extension strength is a 
better predictor of mortality risk than low handgrip strength 
(Mitchell et al. 2012; Laukkanen et al. 1995), and handgrip 
strength alone does not provide a good measure to evaluate 
the effectiveness of interventions in frail populations (Tie-
land et al. 2015).
Methods employed to assess lower body strength are var-
ied, whereby isokinetic dynamometry (Krause et al. 2012; 
Newman et al. 2006; Bouchard et al. 2011), a force trans-
ducer (Yeung et al. 2018), spring gauge (Hairi et al. 2010), 
and adopted proxy measures (Cruz-Jentoft et  al. 2018) 
have been used. Isokinetic dynamometry is often consid-
ered the ‘gold standard’ for lower-body strength testing 
and has been used consistently in studies with older popu-
lations (Lauretani et al. 2003; Brach et al. 2004; Newman 
et al. 2003, 2006; Goodpaster et al. 2006; Scott et al. 2014). 
The availability of such costly and large-scale equipment 
to assess lower body strength might be restricted in clini-
cal and epidemiological settings (Martin et al. 2006; Yeung 
et al. 2018). Therefore, the use of practical exercise train-
ing-specific equipment to establish leg extension strength 
might be a more cost-effective and accessible alternative to 
isokinetic dynamometry. For instance, leg extension one-
repetition maximum (1RM) strength is strongly associated 
with peak torque values obtained using isokinetic dynamom-
etry (r = 0.78–0.88), and to a greater extent than a leg press 
1RM test (r = 0.72–0.77) (Verdijk et al. 2009). The need 
for lower-body strength testing as part of the comprehen-
sive geriatric assessment was highlighted by Yeung et al. 
(2018), who demonstrated stronger associations of health 
characteristics with knee extension strength in comparison 
with handgrip strength in community-dwelling older adults. 
All of the above emphasise the need to assess lower body 
strength and muscle quality in older populations as a means 
to identify individuals at risk of impaired physical function 
and/or sarcopenia.
The objectives of this pilot study were to investigate dif-
ferences in lean tissue mass, muscle strength, functional 
performance, and physical function among healthy young 
and older individuals and establish the relationships of these 
variables with total appendicular lean mass (ALM). We 
then sought to assess the presence of sarcopenia using two 
established definitions with the lowest and highest pooled 
prevalence estimates (Mayhew et al. 2018). We also per-
formed MQ assessment to identify individuals with evidence 
of functional decline and aimed to reconcile these findings 
with sarcopenia definitions.
Materials and methods
Study design
A cross-sectional study involving two testing sessions, sepa-
rated by a minimum period of 7 days but no longer than 
14 days, was conducted between October 2016 and July 
2017. In the first visit, measures of strength, body compo-
sition, functional performance and physical activity were 
taken and participants were familiarised with the lower body 
1RM test. On the second visit, participants completed the 
1RM test only. All procedures were conducted by the same 
trained researcher at the same time of day, under strict con-
trols to mitigate the impact of confounding variables such 
as exercise and diet.
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Participants
Fifty younger (18–45 years; 30 males, 20 females) and 50 
older (60–80 years; 24 males, 26 females) participants were 
randomly recruited from local universities and the wider 
community, using a combination of email communications, 
online or printed advertisements and leaflets. Participant 
characteristics for both groups are provided in Table 1. All 
participants were independently living and free from cardio-
vascular, metabolic, endocrine, or other metabolic disease. 
Participants were excluded if they smoked, used oestrogens 
within the previous 3 months, had a pacemaker, or were tak-
ing any medication known to affect protein metabolism (i.e., 
anabolic steroids, corticosteroids, and peripheral vasodila-
tors). Younger females were excluded if they were using the 
oral contraceptive pill. Participants were randomly recruited 
from a range of sports teams and activity groups, as well as 
from the lay public, to represent a broad range of physical 
activity levels. Written informed consent was provided prior 
to commencing the study and all procedures were carried 
out in accordance with the Helsinki Declaration of 1964, 
following approval by the University Faculty Research Eth-
ics Committee.
Preliminary screening and basic anthropometry
Participants arrived at the laboratory between 07.00 and 
09.00 in a fasted, euhydrated state after avoiding alcohol 
and exercise for a 24 h period. Following an initial brief-
ing, resting heart rate (RHR), systolic and diastolic blood 
pressure (SBP and DBP, respectively) were measured using 
a manual sphygmomanometer (Accoson Greenlight 300, 
Accoson, United Kingdom). Stature (to the nearest 0.1 cm) 
and body mass (to the nearest 0.1 kg) were recorded using a 
stadiometer (Seca 220, Hamburg, Germany) and calibrated 
electronic scales (Seca 220, Hamburg, Germany). Body 
mass index (BMI) was derived by calculating mass/height2. 
Finger capillary blood samples were obtained and analysed 
for total cholesterol, high-density lipoprotein, low-density 
lipoprotein, triglycerides and glucose using a Cholestech 
LDX (Alere San Diego, Inc., San Diego, CA) capillary 
whole blood lipid analyser (Donato et al. 2015).
Body composition assessment
Total-body fat mass, lean tissue mass, bone mineral content 
and percentage tissue fat mass (%TFM) values were ascer-
tained by one total-body dual-energy X-ray absorptiometry 
(DXA) scan (GE Lunar iDXA, GE Healthcare, Madison, 
WI). These data were used to calculate appendicular lean 
mass (ALM). Participants were scanned in a fasted, euhy-
drated state as per established recommendations (Nana 
et al. 2012; Sawka et al. 2007). Participants removed shoes 
and jewellery before receiving the scan, whilst adopting a 
supine position with arms to the side in the semi-prone posi-
tion (Thurlow et al. 2018) and ankles supported with the 
Lunar ankle strap (0.5 cm space between the ankles). Stand-
ard mode scans took approximately 7.5 min to complete, 
whereas those > 100 kg in body mass (n = 2) necessitated 
the use of the thick mode scan, which took approximately 
12.5 min.
The values for the body composition outcomes were 
determined from the ratio of soft tissue attenuation of two 
X-ray energy beams for each pixel containing a minimal 
amount of soft tissue but no significant bone (Mazess et al. 
1990). In our laboratory, the in vivo short-term precision 
(%CV) for total-body composition variables are 0.82% for 
fat mass, 0.51% for lean mass, 0.86% for percentage body 
fat and 0.60% for bone mineral content (Hind et al. 2011). 
The machine was checked and calibrated on a daily basis in 
line with the manufacturer’s recommendations. All scan-
ning and analysis procedures were performed by the same 
trained operator using the Lunar enCORE software package 
(version 15.0).
Functional performance and strength testing
Gait speed was measured directly using a 6-m course and 
photoelectric timing gates (Witty, Microgate, Bolzano, 
Italy). Participants were instructed to walk at their usual pace 
between two gates, with the fastest of these attempts used for 
the final analysis. The established cut-point of < 1 m/s was 
used to characterise impaired physical performance (Cesari 
et al. 2005, 2009; Visser et al. 2002).
Dominant and non-dominant handgrip strength (specific 
force, kg) were assessed using a Takei T.K.K. 5401 GRIP-D 
handgrip dynamometer (Takei Scientific Instruments Co., 
Ltd, Niigata, Japan), with the participant in a seated posi-
tion (knees at 90°) and the shoulders adducted and neutrally 
rotated. The elbow was flexed at 90° with the forearm in a 
Table 1  Participant characteristics and baseline screening for the 
sample population (n = 100)
Data presented as mean ± SD
BMI body mass index, DBP diastolic blood pressure, RHR resting 
heart rate, SBP systolic blood pressure
Variable Young (n = 50) Older (n = 50) P value
Age (years) 23 ± 5 70 ± 4 < 0.0001
Height (cm) 174.8 ± 8.6 166.3 ± 10.1 < 0.0001
Body mass (kg) 74.4 ± 12.0 70.9 ± 15.2 0.202
BMI (kg/m2) 24.2 ± 2.6 25.4 ± 3.7 0.062
RHR (bpm) 64 ± 12 61 ± 10 0.125
SBP (mmHg) 114 ± 10 128 ± 12 < 0.0001
DBP (mmHg) 77 ± 15 80 ± 11 0.312
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neutral position and the wrist in slight extension (0°–30°) 
(De Dobbeleer et al. 2017). The participant was then asked 
to squeeze the handle of the dynamometer as hard as pos-
sible for a maximum of five seconds. The highest of three 
attempts was noted and the process was repeated for the 
non-dominant hand. The previously established cut-points 
of < 30 kg for males and < 20 kg for females, respectively, 
were used for the determination of low grip strength (Lau-
retani et al. 2003).
For testing of lower body strength, participants were 
asked to perform separate 1RM tests of the dominant and 
non-dominant limbs using a Cybex VRS Prestige (Cybex 
International, Medway, MA) leg extension machine. A 5 min 
dynamic warmup was performed, with emphasis on the 
lower body musculature, prior to beginning a protocol-spe-
cific warm-up. Each participant’s 1RM was measured using 
previously described procedures (Baechle and Earle 2008). 
At the initial laboratory visit, participants completed a 1RM 
test for familiarisation purposes which was then repeated on 
the subsequent visit to establish 1RM.
Assessment of habitual physical activity
Participants were asked to provide estimates of physical 
activity over the previous 7 days, using the long form of the 
International Physical Activity Questionnaire (IPAQ). The 
estimated total time spent in the respective domains of occu-
pational, transport, household and leisure-related physical 
activity were calculated. These data were then used to deter-
mine weighted MET-minutes per week (MET min/week) 
for walking, moderate and vigorous activity, respectively 
(Craig et al. 2003). For descriptive purposes, participants 
were classified as high, moderate, or low according to IPAQ 
categorical criteria. Highly active was defined as 7 or more 
days of any combination of walking, moderate-intensity, 
or vigorous-intensity activities, achieving a minimum total 
physical activity of ≥ 3000 MET-min/week. Moderately 
active was defined as 5 or more days of any combination of 
walking, moderate-intensity, or vigorous-intensity activities, 
amounting to a minimum total physical activity of ≥ 600 
MET-min/week. Participants were classified as low if they 
did not meet the criteria for the moderate category.
Sarcopenia classification and muscle quality
Two established definitions were applied to the sample 
groups to establish the prevalence of sarcopenia. ALM 
was calculated as the sum of the fat-free mass in the limbs, 
excluding bone mineral content, divided by body mass and 
expressed as a percentage. This definition has been applied 
and revealed a 40.4% prevalence rate of sarcopenia (May-
hew et al. 2018). In the present study, cut-points of < 27.1% 
for males and < 22.3% for females were used to define 
sarcopenia.
The second definition was the composite measure of the 
International Working Group on Sarcopenia (IWGS) (Field-
ing et al. 2011), representing the lowest prevalence limit 
(9.9%) according to Mayhew et al. (2018). Participants with 
a gait speed of < 1 m/s were identified and subsequently 
screened by lean tissue mass. ALM/height2 was calculated 
and the cut-points of ≤ 7.23 kg/m2 for males and ≤ 5.67 kg/
m2 for females were applied to determine sarcopenia.
Upper-body MQ was calculated by dividing the maxi-
mum handgrip strength by upper body ALM, with cut-points 
determined as < 5.76 kg/kg for males and < 5.475 kg/kg for 
females, respectively (Cooper et al. 2014). Lower-body 
MQ was determined as the ratio of dominant leg extension 
strength to leg lean mass (Hairi et al. 2010). Since to our 
knowledge cut-points for younger populations do not cur-
rently exist, cautious and limited comparisons of upper-body 
MQ for the younger group were made against established 
norms for the older group. Protocol-specific cut-points for 
lower-body MQ using the adopted MQ algorithm do not 
currently exist. Therefore, and in line with the selection of 
cut-points for sarcopenia (Baumgartner et al. 1998), low MQ 
in the lower body was classified as at least two standard 
deviations below the mean of the corresponding younger 
group in the present study, with cut-points of ≤ 2.11 kg/kg 
for males and ≤ 1.56 kg/kg for females, respectively.
Statistical analysis
All statistical analyses were performed using IBM SPSS 
statistics software (Version 24.0, IBM Corp., Armonk, 
NY). Prior to analysis, assumptions of normality in the data 
were made using Shapiro–Wilk tests and visualisation of 
normality plots. Between-group differences were investi-
gated using multivariate analysis of variance (MANOVA). 
Cohen’s d effect sizes were calculated to quantify the mag-
nitude of differences in body composition, functional and 
strength testing, MQ, and estimates of physical activity. 
The effect size thresholds were classified in line with Cohen 
(1988): < 0.2 = trivial; 0.2–0.5 = small; 0.5–0.8 = medium; 
0.8–1.3 = large; > 1.3 = very large.
The relationships between total ALM and strength, func-
tional performance and physical activity were determined 
for each group using Pearson’s correlation coefficients. The 
strength of the relationship was classified according to the 
thresholds of Cohen (1988): small = 0.10, moderate = 0.30, 
large = 0.50. Fisher r-to-z transformations were performed 
to assess the significance of differences in correlation coef-
ficients between groups.
By way of multiple regression analysis using the forced 
entry method, the best predictors of upper and lower body 
ALM were determined for both sample groups. Adjusted 
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R2 and multicollinearity statistics (tolerance and variance 
inflation factor) were used to identify the optimum equa-
tions (Krause et al. 2012; Stoever et al. 2017). For all regres-
sion models, dominant handgrip strength and dominant leg 
extension strength were chosen as the best predictors. For all 
appropriate analyses, 95% confidence intervals (95% CI) are 
reported. All data are presented as mean ± standard devia-
tion (SD) with statistical significance for all analyses set at 
P ≤ 0.05.
Results
Basic anthropometry and preliminary screening
Comparisons of basic anthropometry and preliminary 
screening measures are given in Table 1. The younger group 
was significantly taller and had lower resting systolic blood 
pressure than the older group. No significant differences 
were found for body mass, BMI, resting heart rate, or resting 
diastolic blood pressure. Blood lipid profile components and 
blood pressure in both groups were within established norms 
for metabolically healthy individuals (data not shown).
Body composition assessment
Comparisons of body composition, functional measures and 
strength testing are presented in Table 2. The younger group 
had significantly lower fat mass and %TFM than the older 
group. Lean mass and total ALM were both significantly 
higher in the younger group.
In both groups, lean mass was strongly and significantly 
associated with total ALM (Table 3). In the older group 
only, there was a moderate positive correlation between 
total ALM and fat mass. In the younger group, fat mass was 
negatively associated with lean mass (r = -0.22), however 
this was not statistically significant (P = 0.130). In the older 
group, fat mass was positively associated with lean mass 
(r = 0.53; P < 0.0001). All correlation coefficients were sig-
nificantly different between groups.
Functional measures and strength testing
Upper and lower-body strength testing revealed significantly 
greater strength in the younger group (Table 2). No signifi-
cant differences were found in upper-body MQ, whereas 
lower-body MQ was significantly greater in the younger 
group. Gait speed was significantly faster in the younger 
group.
Table 2  Body composition, 
functional performance, 
physical activity and strength 
testing measures by age group 
(n = 100)
Data presented as mean ± SD
%TFM percentage tissue fat mass, 1RM one repetition maximum, ALM appendicular lean mass, HGS hand-
grip strength, MET metabolic equivalent, MQ muscle quality
Variable Young (n = 50) Older (n = 50) P value Effect size (95% CI)
Body composition
Fat mass (kg) 17.5 ± 6.5 22.6 ± 7.6 0.001 0.72 (0.30, 1.10)
Lean mass (kg) 54.2 ± 11.1 45.0 ± 10.4 < 0.0001 0.85 (0.38, 1.30)
%TFM 24.5 ± 8.4 32.7 ± 7.4 < 0.0001 1.04 (0.64, 1.40)
Total-body ALM (kg) 25.4 ± 6.0 20.1 ± 5.0 < 0.0001 0.96 (0.56, 1.40)
Upper-body ALM (kg) 6.7 ± 2.3 5.0 ± 1.5 < 0.0001 0.88 (0.49, 1.30)
Lower-body ALM (kg) 18.6 ± 3.9 15.1 ± 3.6 < 0.0001 0.93 (0.54, 1.30)
Strength, muscle quality and functional performance
Dominant HGS (kg) 40.4 ± 10.5 29.1 ± 8.5 < 0.0001 1.18 (0.78, 1.60)
Non-dominant HGS (kg) 38.6 ± 10.9 27.3 ± 8.9 < 0.0001 1.13 (0.74, 1.70)
Dominant leg extension 1RM (kg) 58.3 ± 21.4 27.9 ± 8.6 < 0.0001 1.86 (1.46, 2.30)
Non-dominant leg extension 1RM (kg) 56.8 ± 20.1 26.3 ± 8.8 < 0.0001 1.97 (1.57, 2.40)
Upper-body MQ (kg/kg) 6.3 ± 1.3 5.9 ± 1.1 0.136 0.33 (− 0.11, 0.77)
Lower-body MQ (kg/kg) 3.1 ± 0.7 1.9 ± 0.4 < 0.0001 2.10 (1.72, 2.50)
6-m gait speed (m/s) 1.34 ± 0.17 1.21 ± 0.24 0.002 0.63 (0.24, 1.00)
Physical activity
Walking (MET-min/week) 2276 ± 2254 1933 ± 1713 0.393 0.17 (− 0.22, 1.56)
Moderate (MET-min/week) 1537 ± 2068 2124 ± 2393 0.193 0.26 (− 0.13, 0.65)
Vigorous (MET-min/week) 3266 ± 2815 1642 ± 3131 0.008 0.63 (0.17, 1.10)
Total (MET-min/week) 7079 ± 4868 5699 ± 5045 0.167 0.27 (− 0.11, 0.65)
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In both groups, large and significant positive associations 
were found between upper and lower body strength and total 
ALM (Table 3). Negative associations were found between 
upper-body MQ and total ALM in both groups. In addition, a 
large and significant positive association was found between 
lower-body MQ and total ALM in the younger group. None 
of the coefficients differed significantly between groups 
except for dominant leg extension strength and lower-body 
MQ.
Assessment of habitual physical activity
The younger group demonstrated significantly greater levels 
of vigorous activity than the older group. All other com-
parisons were not significantly different between groups. No 
significant associations were found between total ALM and 
IPAQ-derived data in either group, and the correlation coef-
ficients did not differ significantly between groups.
Using the IPAQ categorical classification criteria, the 
younger group was profiled as follows: low = 2, moder-
ate = 7, high = 41. The older group was as follows: low = 1, 
moderate = 16, high = 33.
Sarcopenia classification and muscle quality status
As per the definitions put forward by the IWGS, one older male 
was classified as sarcopenic. When sarcopenia was calculated 
using lean tissue mass as the sole measure, derived from ALM/
body mass, only two older males were classified as sarcopenic.
Upper-body MQ was below established cut-points in 
16 young (14 males, 2 females) and 21 older (14 males, 7 
females) participants. For lower-body MQ, 17 older males 
and 8 older females were at least 2 standard deviations 
below the mean of the corresponding younger group. Nine 
older males had low MQ at both the upper and lower body, 
whereas this was only the case in two older females.
Multiple regression analyses
The results of the multiple regression models for the younger 
group are shown in Table 4. These models accounted for 
82% and 74% of the variance in upper and lower body ALM, 
respectively, using dominant handgrip strength and domi-
nant leg extension strength as predictor variables. The com-
plete equations are as follows:
The same multiple regression models were applied to the 
older group and are shown in Table 5. The models accounted 
Upper body ALM = −0.310 + 0.065 xdominant leg extension 1RM
+ 0.081 xdominant grip strength
Lower body ALM = 7.420 + 0.111 xdominant leg extension 1RM
+ 0.117 xdominant grip strength
Table 3  Correlates of total 
appendicular lean mass by 
age group. Fisher r-to-z 
transformations were performed 
to assess the significance of 
between-group differences in 
correlation coefficients
%TFM percentage tissue fat mass, 1RM one repetition maximum, ALM appendicular lean mass, HGS hand-
grip strength, MET metabolic equivalent, MQ muscle quality
*Significant at P < 0.05; **significant at P < 0.01
Variable Young (n = 50) Older (n = 50) Z score P value
Body composition
Fat mass (kg) − 0.16 0.45** − 3.13 0.002
Lean mass (kg) 0.99** 0.88** 6.16 < 0.001
%TFM − 0.56** − 0.21 − 2.03 0.042
Strength, muscle quality and functional performance
Dominant HGS (kg) 0.78** 0.79** − 0.13 0.897
Non-dominant HGS (kg) 0.78** 0.79** − 0.13 0.897
Dominant leg extension 1RM (kg) 0.87** 0.71** 2.16 0.031
Non-dominant leg extension 1RM (kg) 0.83** 0.74** 1.15 0.250
Upper-body MQ (kg/kg) − 0.61** − 0.31* − 1.88 0.060
Lower-body MQ (kg/kg) 0.51** − 0.04 2.92 0.004
6-m gait speed (m/s) − 0.14 0.00 − 0.68 0.497
Physical activity
Walking (min/week) − 0.03 − 0.17 0.69 0.490
Moderate (min/week) − 0.13 − 0.21 0.40 0.689
Vigorous (min/week) 0.08 0.18 − 0.49 0.624
Total (MET-min/week) − 0.03 − 0.05 0.01 0.920
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for 72% and 68% of the variance in upper and lower body 
ALM, using the same respective predictors. The complete 
equations are as follows:
Discussion
The aims of the present pilot study were to investigate 
differences in lean tissue mass, functional capacity and 
physical activity between younger and older individuals 
Upper body ALM = 0.330 + 0.072xdominant leg extension 1RM
+ 0.093xdominant grip strength
Lower body ALM = 3.865 + 0.147xdominant leg extension 1RM
+ 0.244xdominant grip strength
and to establish relationships between these variables and 
total ALM. Muscle quality assessment was performed at 
the upper and lower body, and these findings were rec-
onciled with two established definitions of sarcopenia. 
Finally, regression analyses were performed to investigate 
the application of upper and lower body ALM for use as 
a proxy measure of MQ. The major findings of this study 
suggest that in spite of low sarcopenia rates (2–4% using 
two established definitions) in our older population, 42% 
had low upper-body MQ, as per existing thresholds. Inter-
estingly, 32% of the younger group were also below these 
thresholds. In spite of the absence of protocol-specific 
benchmarks for lower-body MQ, we found that 50% of 
the older group had MQ values at least two standard devia-
tions below the mean for the respective younger groups.
Table 4  Results of the multiple 
regression models for the 
prediction of upper and lower 
body ALM in young individuals 
(n = 50)
R = 0.91 and R2 = 0.82 for upper body regression model; R = 0.86 and R2 = 0.74 for lower body regression 
model
1RM one-repetition maximum, ALM appendicular lean mass, HGS handgrip strength, VIF variance infla-
tion factor
Model Unstandardised coefficients Standardised 
coefficients
P value Collinearity 
statistics
B (95% CI) SE Beta Tolerance VIF
Upper body ALM
Constant − 0.310 (− 1.436, 0.817) 0.560 0.583
Dominant leg 1RM 0.065 (0.046, 0.083) 0.009 0.607 < 0.00001 0.518 1.930
Dominant HGS 0.081 (0.044, 0.119) 0.019 0.373 < 0.0001 0.518 1.930
Lower body ALM
Constant 7.420 (5.119, 9.720) 1.143 < 0.00001
Dominant leg 1RM 0.111 (0.074, 0.148) 0.019 0.613 < 0.00001 0.518 1.930
Dominant HGS 0.117 (0.040, 0.193) 0.038 0.315 0.004 0.518 1.930
Table 5  Results of the multiple 
regression models for the 
prediction of upper and lower 
body ALM in older individuals 
(n = 50)
R = 0.85 and R2 = 0.72 for upper body regression model; R = 0.83 and R2 = 0.68 for lower body regression 
model
1RM one-repetition maximum, ALM appendicular lean mass, HGS handgrip strength, VIF variance infla-
tion factor
Model Unstandardised coefficients Standardised 
coefficients
P value Collinearity 
statistics
B (95% CI) SE Beta Tolerance VIF
Upper body ALM
Constant 0.330 (− 0.561, 1.220) 0.443 0.460
Dominant leg 1RM 0.072 (0.039, 0.104) 0.016 0.418 < 0.0005 0.655 1.526
Dominant HGS 0.093 (0.059, 0.126) 0.017 0.533 < 0.00001 0.655 1.526
Lower body ALM
Constant 3.865 (1.542, 6.188) 1.155 0.002
Dominant leg 1RM 0.147 (0.061, 0.233) 0.043 0.350 0.001 0.655 1.526
Dominant HGS 0.244 (0.157, 0.331) 0.043 0.571 < 0.00001 0.655 1.526
 European Journal of Applied Physiology
1 3
Our findings show that the younger group possessed 
lower fat mass and %TFM than the older group. Greater 
lean mass and ALM were also found in the younger group, 
with all comparisons supported by large effect sizes. These 
observations corroborate those of previous studies, sug-
gesting that fat mass increases and lean mass decreases 
with age, without substantial differences in body mass (St-
Onge and Gallagher 2010; Mazariegos et al. 1994; Atlantis 
et al. 2008).
Fat mass was positively correlated with both total ALM 
and lean mass in the older group only, and these findings 
concur with previous studies (Bouchard et al. 2011; Lebrun 
et al. 2006). This relationship may be important for clinical 
outcomes. Low fat mass and lean tissue mass pose the great-
est risk of all-cause mortality in older individuals (Spahillari 
et al. 2016). Conversely, greater lean tissue mass is associ-
ated with improved overall mortality in older individuals 
(Spahillari et al. 2016). Greater fat mass is associated with 
a decreased risk of adverse events in hospitalised elderly 
patients (Bouillanne et al. 2009). Additionally, the over-
weight classification for the older group in the present study 
is associated with the lowest mortality rate in this popula-
tion (Chang et al. 2012; Kvamme et al. 2012; Bouillanne 
et al. 2009). Together, these findings support the notion 
that lean tissue mass improvements should be emphasised 
in older adults ahead of measures such as BMI (Spahillari 
et al. 2016).
In the present study, maximal strength at the upper and 
lower body was significantly greater in the young, consti-
tuting large and very large effects, respectively. These find-
ings are in line with previous literature that showed greater 
torque, normalised torque and power in younger versus 
older men, with the lower body affected more substantially 
than the upper body (Candow and Chilibeck 2005). Gait 
speed was significantly lower in the older group (moder-
ate effect), and our findings correspond with Laufer (2005), 
who observed reduced forward walking velocity in older 
compared to younger individuals.
Upper-body MQ did not differ significantly between 
groups (small effect). In the older group, upper-body MQ 
was similar to that observed by Hairi et al. (2010), albeit 
in the 80–84 year old age group. Low upper-body MQ 
was prevalent in 42% of the older group, and in 32% of the 
younger group based on established cut-points (Cooper et al. 
2014). The latter finding should be treated with caution since 
the aforementioned cut-points are age-specific. Nevertheless, 
this emphasises the need for further work to develop and 
establish age-specific MQ cut-points. The negative associa-
tions between total ALM and upper-body MQ in both groups 
are explained as a function of the MQ equation, in that the 
denominator (total ALM) includes tissue (i.e., lower body 
ALM) that has no impact on force production during hand-
grip strength assessment.
Lower-body MQ was significantly greater in the young 
(very large effect). It must also be noted that no protocol-
specific cut-point thresholds have been defined for lower-
body MQ metrics in young and older individuals, and this 
represents an avenue for future research. In contrast with 
upper-body MQ, lower-body MQ was positively associ-
ated with total ALM in the young; however, no effect was 
found for this variable in the older group. The absence of an 
association between total ALM and lower-body MQ in the 
older group warrants further exploration. Muscle quality has 
been shown to decline progressively with age, potentially 
as a result of neurological factors, such as decrements in 
excitation contraction coupling and motor nerve conduc-
tion velocity (Moore et al. 2014; Clark and Manini 2012). 
Therefore, our findings suggest that measures of lean mass 
and sarcopenia definitions cannot solely be used to deter-
mine musculoskeletal health in young and older adults, and 
reinforce the rationale for MQ assessment of the upper and 
lower body (Cruz-Jentoft et al. 2018).
Self-reported physical activity was significantly higher in 
the younger group for vigorous activities (moderate effect), 
whereas all other comparisons were non-significant between 
groups. No significant associations were found between total 
ALM and IPAQ-derived data in each group and the correla-
tion coefficients did not significantly differ. These findings 
lend further support to the use of strength testing to predict 
ALM, whilst demonstrating that IPAQ data cannot be used 
to predict ALM.
In totality, our findings lend support for the assessment 
of lower-body strength testing and reinforce the impor-
tance of this metric as a key predictor of physical perfor-
mance and function (Marsh et al. 2006; Coelho-Junior et al. 
2018; Yeung et al. 2018; Bouchard et al. 2011). The use 
of handgrip strength testing is ubiquitous in the literature 
(Bischoff-Ferrari et al. 2015; Newman et al. 2003, 2006; 
Stoever et al. 2017; Lauretani et al. 2003), given its use as a 
highly efficient screening tool (Martin et al. 2006). Despite 
this, handgrip strength may misclassify individuals as it only 
accounts for ~ 40% of the variance in lower body strength 
(Manini and Clark 2012). Moreover, caution should be 
observed when characterising overall strength based on the 
use of a single measurement tool (Bohannon 2008; Mitchell 
et al. 2012; Tieland et al. 2015). In older adults, differential 
associations have been noted between health characteristics, 
knee extension strength and handgrip strength, to the extent 
that lower-body strength testing poses considerable addi-
tive value (Yeung et al. 2018). Therefore, we support the 
inclusion of lower-body strength testing in addition to that 
of handgrip strength to enable better prediction of ALM in 
older adults. The measurement of leg extension strength 
using cost-effective and practical equipment appears to be a 
useful alternative to isokinetic dynamometry, and aligns well 
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with recent recommendations concerning strength testing in 
older adults (Cruz-Jentoft et al. 2018).
In conclusion, an important finding of the present study 
was the low number of older individuals identified as sar-
copenic, and the similarity of two established definitions in 
detecting these individuals despite large pooled prevalence 
differences between definitions (Mayhew et al. 2018). Defi-
cits in upper-body MQ were found in the younger (n = 16) 
and older (n = 21) groups. Furthermore, 25 older individuals 
had low MQ at the lower body. Eleven of the older individu-
als had low ‘global’ MQ (i.e., upper and lower), representing 
22% of the older group. These findings lend support to the 
rationale for conducting MQ testing alongside established 
sarcopenia definitions to effectively identify individuals 
at risk of functional decline. Future studies should seek to 
investigate the veracity of our regression models in a larger 
and more diverse sample population. In this manner, MQ at 
the upper and lower body might be estimated using strength 
measures and implemented as a practical prognostic tool. 
Individuals with low ‘estimated’ MQ may then be referred 
for DXA imaging as necessary to confirm or deny the pres-
ence of sarcopenia and/or impaired MQ.
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